Navy Yard Skills Initiative Begins Recruitment for Philly Shipyard, Inc. – Union Apprentice

University City District’s West Philadelphia Skills Initiative (WPSI) and PIDC’s Navy Yard Skills Initiative (NYSI) are recruiting across Philadelphia for training and job opportunities as a Union Apprentice earning $17.13/hour to start in partnership with Philly Shipyard, Inc. Register online for a virtual info session to learn more about the program: August 25th at 1PM

Easily Fill Your Prescriptions at the Jefferson Navy Yard Pharmacy

Did you know that the Navy Yard has a pharmacy? That’s right, the Jefferson Navy Yard Pharmacy at 3 Crescent Drive features a full-service pharmacy that accepts all Rx plans. “I think people are under the assumption that the pharmacy is only for patients at Jefferson Health,” said Ernie Cotilus III, RPh, Pharmacy Supervisor at

The Navy Yard Welcomes Vinta Bio

The Navy Yard is pleased to welcome Vinta Bio, our newest life sciences company, to the Navy Yard community located at 4050 S. 26th Street, Suite 200. Vinta Bio, a contract development and manufacturing organization (CDMO), is focused on helping customers develop and manufacture viral vectors and cell therapy products. Its vision is to grow

The Navy Yard Welcomes FKB Studios

The Navy Yard is pleased to welcome FKB Studios who recently located to Building 990! FKB is a cutting edge and innovative design and fabrication company specializing in creating immersive spaces. It is the exciting result of the recent merger of two established Philadelphia-based design and fabrication companies: FK Productions and B Fabrication. Together, FKB

2022 Navy Yard Plan Unveiled

Media contacts:Jennifer Tran, PIDC, 215-218-2854Robbie Tarpley Raffish, a.s.a.p.r., 410-430-9705 Press Kit with Renderings Available at https://bit.ly/navyyardplanpressCREDIT: Renderings by James Corner Field Operations, courtesy of PIDC and Ensemble/Mosaic 2022 Navy Yard Plan Unveiled, Focused on Job Creation, Equitable Growth, & Increased Accessibility PIDC and Ensemble/Mosaic today unveiled the 2022 Navy Yard Plan, a transformative roadmap for equitable

The Navy Yard Welcomes: Maho Construction

We are pleased to welcome Maho Construction LLC to the Navy Yard community. Maho Construction was established in 2019 as a commercial carpentry outfit specializing in all aspects of carpentry. With over 40 years of combined construction experience Maho Construction has established quality relationships with several property developers, Higher education, Industrial & Healthcare facilities management

The Navy Yard Welcomes: TB12

The Navy Yard is pleased to welcome TB12 Performance & Recovery Center to Philadelphia and the Navy Yard community! TB12 is transforming global health & wellness by empowering athletes and everyone looking to live an active lifestyle, to prevent injury, improve longevity, and perform their best. The TB12 Method, inspired by the training method of

WuXi ATU Opens New Facility in Philadelphia, Tripling Testing Capacity to Support Global Customers

WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced the official opening of its advanced therapies testing facility at 400 Rouse Boulevard in Philadelphia’s Navy Yard. The new facility, which includes 140,000 square feet laboratories, will further enhance the company’s Contract Testing, Development and Manufacturing Organization (CTDMO) business model by tripling the company’s previous

Navy Yard Electric Utility Transitions Operations to Dominion Energy

Today Dominion Energy takes over the 10-year electric utility Operations and Maintenance (O&M) services contract for the Navy Yard. This contract was the culmination of a lengthy, highly competitive solicitation process announced in May 2021. Dominion Energy will provide responsive on-site management to the Navy Yard and its customers, who will gain industry-leading service reliability, financial

Iovance Biotherapeutics Celebrates Grand Opening of Iovance Cell Therapy Center (iCTC)

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies (tumor-infiltrating lymphocyte, TIL, and peripheral-blood lymphocyte, PBL), is celebrating the official opening of the Iovance Cell Therapy Center (iCTC). The iCTC, located at the Philadelphia Navy Yard, is the first centralized, scalable, state-of-the-art manufacturing facility dedicated to producing TIL cell therapies for patients with